The Cooper Companies, Inc.’s Stock Price Plummets to $78.03, Witnessing a 4.13% Drop: A Detailed Analysis

The Cooper Companies, Inc. (COO)

78.03 USD -3.37 (-4.13%) Volume: 4.12M

The Cooper Companies, Inc.’s stock price is currently trading at 78.03 USD, witnessing a drop of -4.13% in this trading session with a trading volume of 4.12M. The stock has experienced a decline of -11.45% Year-to-Date (YTD), reflecting its performance in the market.

Latest developments on The Cooper Companies, Inc.

The Cooper Companies (COO) saw a 5.2% increase in stock price today following a series of key events. The company recently completed a strategic review and buyback, boosting investor confidence. Additionally, their 2026 outlook highlighted strong growth potential despite market challenges. Cooper Cos’ international revenue performance was also explored, further solidifying their position in the market. Overall, these developments have contributed to the positive movement in their stock price today.

A look at The Cooper Companies, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Looking at the Smartkarma Smart Scores for Cooper Cos, the company seems to have a promising long-term outlook. With a strong momentum score of 4, Cooper Cos is showing positive growth potential and market performance. This is complemented by a growth score of 3, indicating that the company is likely to continue expanding its market presence and profitability over time. While the dividend score is lower at 1, suggesting lower returns for shareholders in terms of dividends, the overall outlook for Cooper Cos appears to be positive.

The Cooper Companies, Inc. is a company that specializes in developing, manufacturing, and marketing specialty healthcare products. Their range of products includes contact lenses for the vision care market as well as diagnostic products, surgical instruments, and accessories for gynecologists and obstetricians. With a value score of 3 and a resilience score of 2, Cooper Cos demonstrates a balance of value for investors and the ability to withstand market challenges. Overall, the company’s Smartkarma Smart Scores paint a picture of a company with solid growth potential and market performance in the healthcare industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma